Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Oncotarget|February 25, 2016
CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditisGal Markel, Massimo Imazio, Nira Koren-Morag, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 functionTsufit Gonen-Gross, Hagit Achdout, Roi Gazit, et al.
Blood|May 6, 2003
CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cellsJacob Hanna, Ori Wald, Debra Goldman-Wohl, et al.
European Journal of Immunology|June 24, 2004
Recognition of Mycoplasma hyorhinis by CD99-Fc moleculeRoi Gazit, Hagai Rechnitzer, Hagit Achdout, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Intercellular transfer of carcinoembryonic antigen from tumor cells to NK cellsNoam Stern-Ginossar, Shlomo Nedvetzki, Gal Markel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2019
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective studyJair Bar, Gal Markel, Teodor Gottfried, et al.
Oncoimmunology|May 7, 2020
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactionsErez Nissim Baruch, Rona Ortenberg, Camila Avivi, et al.
Anticancer Research|April 1, 2009
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinomaGal Markel, Tali Cohen-Sinai, Michal J Besser, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Oncotarget|February 25, 2016
CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditisGal Markel, Massimo Imazio, Nira Koren-Morag, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 functionTsufit Gonen-Gross, Hagit Achdout, Roi Gazit, et al.
Blood|May 6, 2003
CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cellsJacob Hanna, Ori Wald, Debra Goldman-Wohl, et al.
European Journal of Immunology|June 24, 2004
Recognition of Mycoplasma hyorhinis by CD99-Fc moleculeRoi Gazit, Hagai Rechnitzer, Hagit Achdout, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Intercellular transfer of carcinoembryonic antigen from tumor cells to NK cellsNoam Stern-Ginossar, Shlomo Nedvetzki, Gal Markel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2019
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective studyJair Bar, Gal Markel, Teodor Gottfried, et al.
Oncoimmunology|May 7, 2020
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactionsErez Nissim Baruch, Rona Ortenberg, Camila Avivi, et al.
Anticancer Research|April 1, 2009
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinomaGal Markel, Tali Cohen-Sinai, Michal J Besser, et al.
Pageof 14